Sarepta Therapeutics
SRPT
#4401
Rank
ยฃ1.75 B
Marketcap
ยฃ16.71
Share price
-2.45%
Change (1 day)
-83.12%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Market capitalization of Sarepta Therapeutics (SRPT)

Market cap: ยฃ1.75 Billion

As of December 2025 Sarepta Therapeutics has a market cap of ยฃ1.75 Billion. This makes Sarepta Therapeutics the world's 4401th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sarepta Therapeutics from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ1.75 B-81.07%
2024ยฃ9.24 B30.61%
2023ยฃ7.08 B-24.69%
2022ยฃ9.40 B61.86%
2021ยฃ5.80 B-41.15%
2020ยฃ9.87 B33.41%
2019ยฃ7.39 B21.09%
2018ยฃ6.11 B129.64%
2017ยฃ2.66 B119.26%
2016ยฃ1.21 B2.16%
2015ยฃ1.18 B209.39%
2014ยฃ0.38 B-17.64%
2013ยฃ0.46 B-7.88%
2012ยฃ0.50 B677.8%
2011ยฃ65.06 M-57.83%
2010ยฃ0.15 B54.77%
2009ยฃ99.69 M212.04%
2008ยฃ31.94 M-30.16%
2007ยฃ45.74 M-47.02%
2006ยฃ86.34 M-15.68%
2005ยฃ0.10 B131.45%
2004ยฃ44.24 M-43.58%
2003ยฃ78.41 M-5.33%
2002ยฃ82.83 M-52.64%
2001ยฃ0.17 B155.51%
2000ยฃ68.45 M25.27%
1999ยฃ54.64 M70.2%
1998ยฃ32.1 M-30.43%
1997ยฃ46.14 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Sarepta Therapeutics was reported to be:

ยฃ1.75 Billion
by Nasdaq info icon info icon
ยฃ1.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
ยฃ112.90 B 6,348.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.84 B-51.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
ยฃ8.10 B 362.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ1.19 B-31.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ45.43 B 2,494.74%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
ยฃ4.65 B 165.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
ยฃ32.65 B 1,765.24%๐Ÿ‡บ๐Ÿ‡ธ USA